Clinical Trial Update: Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) [Phase 3]

View source ↗

Summary

This document provides an update on the Phase 3 MATISSE study evaluating palifosfamide-tris in combination with carboplatin and etoposide for chemotherapy-naïve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Palifosfamide Tris (palifosfamide tris)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN